Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy

Davis Benjamin B., Zeki Amir A., Bratt Jennifer M., Wang Lei, Filosto Simone, Walby William F., Kenyon Nicholas J., Goldkorn Tzipora, Schelegle Edward S., Pinkerton Kent E.

Source: Eur Respir J 2013; 42: 350-361
Journal Issue: August
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Davis Benjamin B., Zeki Amir A., Bratt Jennifer M., Wang Lei, Filosto Simone, Walby William F., Kenyon Nicholas J., Goldkorn Tzipora, Schelegle Edward S., Pinkerton Kent E.. Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy. Eur Respir J 2013; 42: 350-361

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Quercetin attenuates inflammation in cigarette smoke stimulated airway epithelial cells: Possible involvement of autophagy
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013


Tiotropium inhalation prevents acute cigarette smoke-induced airway inflammation in mice
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009

Effects of N-acetylcysteine on airway inflammation, airway hyperresponsiveness and abnormal lung function in chronic ozone-induced COPD model
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Inhaled corticosteroids attenuate epithelial mesenchymal transition: implications for COPD and lung cancer prophylaxis
Source: Eur Respir J, 54 (1) 1900778; 10.1183/13993003.00778-2019
Year: 2019



Losartan reduces cigarette smoke-induced airway inflammation and mucus hypersecretion
Source: ERJ Open Res, 7 (1) 00394-2020; 10.1183/23120541.00394-2020
Year: 2021



P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019


Tiotropium effects on airway inflammatory events in the cat as an animal model for acute cigarette smoke-induced lung inflammation
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012

Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma
Source: Annual Congress 2008 - Basic science in asthma and COPD
Year: 2008

Curcumin inhibits COPD-like airway inflammation and lung cancer promotion in mice
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Simvastatin potentially reduces airway neutrophilia & remodelling in lung allografts
Source: Eur Respir J 2006; 28: Suppl. 50, 120s
Year: 2006

LPS accelerates cigarette smoke-induced deterioration in respiratory function and airway inflammation in mice
Source: Annual Congress 2007 - New treatments for asthma and COPD - experimental evidence
Year: 2007


Mitochondria-targeted H2S suppresses and reverses cigarette smoke-induced inflammasome activity and lung injury in experimental COPD
Source: ERS Lung Science Conference 2020
Year: 2020

Effects of corticosteroid or montelukast associated to iNOS inhibition on inflammation and remodelling of distal lung in animals with chronic inflammation
Source: Annual Congress 2010 - Models of airways disease
Year: 2010


PP201 – Therapeutic targeting of iBALT induces lung regeneration in COPD
Source: ERS Lung Science Conference 2021
Year: 2021

Osteopontin deficiency protects from airway remodelling and hyperresponsiveness in chronic asthma
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009


Ceramide-1-phosphate inhibits cigarette smoke-induced airway inflammation
Source: Eur Respir J 2015; 45: 1669-1680
Year: 2015



Effects of corticosteroid or montelukast associated to iNOS inhibitior on inflammation and remodelling of distal lung in animals with chronic inflammation
Source: Annual Congress 2011 - Translational models of disease
Year: 2011


Glucagon inhibits airway hyperreactivity and lung inflammation in a murine model of acute lung injury
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015